CYP2C19 Genotype Has a Greater Effect on Adverse Cardiovascular Outcomes Following Percutaneous Coronary Intervention and in Asian Populations Treated With Clopidogrel
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.